Aldose reductase inhibition in diabetes.
D000449:Aldehyde Reductase / Q000037:antagonists & inhibitors*; D000818:Animals; D002986:Clinical Trials as Topic; D003921:Diabetes Mellitus, Experimental / Q000201:enzymology; D003922:Diabetes Mellitus, Type 1 / Q000201:enzymology* / Q000378:metabolism / Q000503:physiopathology; D003929:Diabetic Neuropathies / Q000201:enzymology / Q000378:metabolism / Q000503:physiopathology; D004913:Erythrocytes, Abnormal; D006801:Humans; D007093:Imidazoles / Q000009:adverse effects / Q000494:pharmacology*; D048289:Imidazolidines; D051381:Rats; D013012:Sorbitol / Q000378:metabolism; D013401:Sugar Alcohol Dehydrogenases / Q000037:antagonists & inhibitors*
D007093:Imidazoles; D048289:Imidazolidines; D013012:Sorbitol; D013401:Sugar Alcohol Dehydrogenases; D000449:Aldehyde Reductase; C026411:sorbinil